Suven Life Sciences Q3 Results

  • BSE: 530239
  • NSE: SUVEN
  • ISIN: INE495B01038
  • Sector: Biotechnology & Drugs
BSE
118.51.05 (0.89%)
Volume10.13 K
Updated: Mon 25 Nov, 2024 | 15:29:05
NSE
118.51.03 (0.88%)
Volume1.38 L
Updated: Mon 25 Nov, 2024 | 15:29:57
Today: 117.90
120.55
52-Wk: 75.95
169.00

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Suven Life Sciences Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 2.453.06-%3.00-%
    Selling/ General/ Admin Expenses Total 5.794.45-%4.76-%
    Depreciation/ Amortization 1.601.73-%1.67-%
    Other Operating Expenses Total 1.231.62-%0.98-%
    Total Operating Expense 50.2520.84-%56.26-%
    Operating Income -47.80-17.78-%-53.26-%
    Net Income Before Taxes -41.76-12.68-%-51.12-%
    Net Income -41.76-12.68-%-51.12-%
    Diluted Normalized EPS -1.92-0.92-%-2.67-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts